Cargando…
End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations
Antibody-based T cell-activating biologics are promising therapeutic medicines being developed for a number of indications, mainly in the oncology field. Among those, T cell bispecific antibodies are designed to bind one tumor-specific antigen and the T cell receptor at the same time, leading to a r...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850176/ https://www.ncbi.nlm.nih.gov/pubmed/36687375 http://dx.doi.org/10.1016/j.ijpx.2023.100157 |